Drug details

Fluarix Quadrivalent 2021-2022 (influenza virus vaccine)

type of

Fluarix Quadrivalent (influenza vaccine) is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

This drug may have the following side effects:

• loss of appetite,
• joint pain,
• muscle aches,
• headache,
• fatigue,
• drowsiness,
• irritability,
• fever.
• injection site reactions (pain, redness, swelling),
• shivering, and
• gastrointestinal symptoms (nausea, vomiting, diarrhea, and/or abdominal pain),

The following drugs are related to Fluarix Quadrivalent 2021-2022, either as a replacement or used together:

• Afluria Quadrivalent 2016 (afluria quadrivalent 2016)
• Xofluza (baloxavir marboxil)
• Fluarix (influenza virus vaccine)
• Fludara (fludarabine)
• FluMist (influenza virus vaccine)
• Tamiflu (oseltamivir phosphate)
• Relenza (zanamivir)